Tao Huang, PhD, JD, Venture Partner, Cenova Capital; Co-founder, President and CEO of NeuCyte, Inc.,
Dr. Tao Huang has over 25+ years of experience in R&D (RNA biology, neuroscience, oncology), IP/legal, investment and management.
Dr. Huang received a B.Sc. in Biophysics from Nankai University, a Ph.D. in Biochemistry from Peking Union Medical College's Chinese Academy of Medical Sciences, a J.D. from the University of Michigan Law School and obtained his post-doctoral training in molecular biology and biochemistry from Princeton University.
Dr. Tao Huang has over 25+ years of experience in R&D (RNA biology, neuroscience, oncology), IP/legal, investment and management.
Dr. Huang received a B.Sc. in Biophysics from Nankai University, a Ph.D. in Biochemistry from Peking Union Medical College's Chinese Academy of Medical Sciences, a J.D. from the University of Michigan Law School and obtained his post-doctoral training in molecular biology and biochemistry from Princeton University.
Speaking In
4:00 PM - 5:00 PM (PDT)
Tuesday, October 13
Deloitte reports a cooling down effect in biopharma cross-border transactions in 2019 due political…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
